1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Prostatic Neoplasms, Castration-Resistant: new trials by email Literature Review of Prostatic Neoplasms, Castration-Resistant trials Research Report on Prostatic Neoplasms, Castration-Resistant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer 18F-Fluciclovine PET/CT Scan - Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant | Phase 4 | Recruiting | VA Greater Los Angeles Healthcare System | 15 | 2024-12-15 | 2024-11-27 |
| Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects Enzalutamide - Prostatic Neoplasms, Castration-Resistant | Phase 4 | Completed | Radboud University Medical Center | 57 | 2019-05-30 | 2024-06-12 |
| Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer GnRH agonist/antagonist, Prednisone, Abiraterone Acetate - Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma | Phase 4 | Active not recruiting | Northwestern University | 100 | 2017-03-31 | 2026-02-24 |
Prostatic Neoplasms (2) · Cognitive Dysfunction (1) · Dementia (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Urogenital Neoplasms (1)
Genital Diseases (3) · Urogenital Diseases (3) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Neoplasms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Mental Disorders (1)
enzalutamide (2) · Abiraterone Acetate (1) · Gonadotropin-Releasing Hormone (1) · Prednisone (1)
Northwestern University (1) · Radboud University Medical Center (1) · VA Greater Los Angeles Healthcare System (1)
United States (2) · Netherlands (1)
David VanderWeele, M.D., M.P.H. (1)